Why are MAO inhibitors prescribed to people with neurological disorders?

Monoamine oxidase (MAO) breaks down monoamine neurotransmitters, including dopamine. In Parkinson’s disease, dopamine levels are low, so MAO inhibitors can reduce dopamine breakdown and help preserve the dopamine that remains. Thus, the correct choice is to prevent the breakdown of dopamine in Parkinson’s disease.

AI-written and checked against the verified answer.